For the very first time, an Iranian biologist together with his two daughters have managed to identify a diagnostic antigen for multiple sclerosis (MS) after 11 years of studies. They are now on the verge of finding a cure for this disease.
According to a recent study, women with lower level of Vitamin D in the blood may be at a higher risk of developing multiple sclerosis (MS), a disease which primarily affects the brain and spinal cord.
Iran has excelled at diagnosing and treating multiple sclerosis (MS) in the Middle East, said secretary of the 13th International Multiple Sclerosis (MS) Congress, which was held in the capital Tehran on November 9-11.
Multiple sclerosis (MS) may be triggered by the death of brain cells that make the insulation around nerve fibers, a surprising new view of the disease reported in a study from Northwestern Medicine and The University of Chicago. And a specially developed nanoparticle prevented MS even after the death of those brain cells, an experiment in the study showed, phys.org reported.
Genetic findings support observational evidence that lower vitamin D levels are associated with increased risk of multiple sclerosis (MS), according to a new research by Brent Richards, from McGill University.